Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 86

1.

Gene network analyses point to the importance of human tissue kallikreins in melanoma progression.

Martins WK, Esteves GH, Almeida OM, Rezze GG, Landman G, Marques SM, Carvalho AF, L Reis LF, Duprat JP, Stolf BS.

BMC Med Genomics. 2011 Oct 27;4:76. doi: 10.1186/1755-8794-4-76.

2.

Cell cycle gene networks are associated with melanoma prognosis.

Wang L, Hurley DG, Watkins W, Araki H, Tamada Y, Muthukaruppan A, Ranjard L, Derkac E, Imoto S, Miyano S, Crampin EJ, Print CG.

PLoS One. 2012;7(4):e34247. doi: 10.1371/journal.pone.0034247. Epub 2012 Apr 20.

3.

Gene expression profiling of primary cutaneous melanoma and clinical outcome.

Winnepenninckx V, Lazar V, Michiels S, Dessen P, Stas M, Alonso SR, Avril MF, Ortiz Romero PL, Robert T, Balacescu O, Eggermont AM, Lenoir G, Sarasin A, Tursz T, van den Oord JJ, Spatz A; Melanoma Group of the European Organization for Research and Treatment of Cancer.

J Natl Cancer Inst. 2006 Apr 5;98(7):472-82.

PMID:
16595783
4.

Gene expression signatures for tumor progression, tumor subtype, and tumor thickness in laser-microdissected melanoma tissues.

Jaeger J, Koczan D, Thiesen HJ, Ibrahim SM, Gross G, Spang R, Kunz M.

Clin Cancer Res. 2007 Feb 1;13(3):806-15.

5.

Progression in cutaneous malignant melanoma is associated with distinct expression profiles: a tissue microarray-based study.

Alonso SR, Ortiz P, Pollán M, Pérez-Gómez B, Sánchez L, Acuña MJ, Pajares R, Martínez-Tello FJ, Hortelano CM, Piris MA, Rodríguez-Peralto JL.

Am J Pathol. 2004 Jan;164(1):193-203.

6.

Expression and localization of tissue kallikrein mRNAs in human epidermis and appendages.

Komatsu N, Takata M, Otsuki N, Toyama T, Ohka R, Takehara K, Saijoh K.

J Invest Dermatol. 2003 Sep;121(3):542-9.

7.

Gene Network Rewiring to Study Melanoma Stage Progression and Elements Essential for Driving Melanoma.

Kaushik A, Bhatia Y, Ali S, Gupta D.

PLoS One. 2015 Nov 11;10(11):e0142443. doi: 10.1371/journal.pone.0142443. eCollection 2015.

8.

Melanoma progression, gene expression and DNA microarrays.

Hoek KS.

G Ital Dermatol Venereol. 2009 Feb;144(1):39-49. Review.

PMID:
19218910
9.

The antiangiogenic tissue kallikrein pattern of endothelial cells in systemic sclerosis.

Giusti B, Serratì S, Margheri F, Papucci L, Rossi L, Poggi F, Magi A, Del Rosso A, Cinelli M, Guiducci S, Kahaleh B, Matucci-Cerinic M, Abbate R, Fibbi G, Del Rosso M.

Arthritis Rheum. 2005 Nov;52(11):3618-28.

10.

Multiple markers for melanoma progression regulated by DNA methylation: insights from transcriptomic studies.

Gallagher WM, Bergin OE, Rafferty M, Kelly ZD, Nolan IM, Fox EJ, Culhane AC, McArdle L, Fraga MF, Hughes L, Currid CA, O'Mahony F, Byrne A, Murphy AA, Moss C, McDonnell S, Stallings RL, Plumb JA, Esteller M, Brown R, Dervan PA, Easty DJ.

Carcinogenesis. 2005 Nov;26(11):1856-67. Epub 2005 Jun 15.

PMID:
15958521
11.

The promise of microarray technology in melanoma care.

Kim CJ, Reintgen DS, Yeatman TJ.

Cancer Control. 2002 Jan-Feb;9(1):49-53. Review.

PMID:
11907466
12.

An overview of the kallikrein gene families in humans and other species: emerging candidate tumour markers.

Yousef GM, Diamandis EP.

Clin Biochem. 2003 Sep;36(6):443-52. Review.

PMID:
12951170
13.

Differential gene expression profiling of primary cutaneous melanoma and sentinel lymph node metastases.

Koh SS, Wei JP, Li X, Huang RR, Doan NB, Scolyer RA, Cochran AJ, Binder SW.

Mod Pathol. 2012 Jun;25(6):828-37. doi: 10.1038/modpathol.2012.32. Epub 2012 Mar 9.

14.

Network-guided analysis of genes with altered somatic copy number and gene expression reveals pathways commonly perturbed in metastatic melanoma.

Valsesia A, Rimoldi D, Martinet D, Ibberson M, Benaglio P, Quadroni M, Waridel P, Gaillard M, Pidoux M, Rapin B, Rivolta C, Xenarios I, Simpson AJ, Antonarakis SE, Beckmann JS, Jongeneel CV, Iseli C, Stevenson BJ.

PLoS One. 2011 Apr 8;6(4):e18369. doi: 10.1371/journal.pone.0018369.

15.
16.
17.

Gene expression profiling of human melanoma cell lines with distinct metastatic potential identifies new progression markers.

Bertucci F, Pages C, Finetti P, Rochaix P, Lamant L, Devilard E, Nguyen C, Houlgatte R, Birnbaum D, Xerri L, Brousset P.

Anticancer Res. 2007 Sep-Oct;27(5A):3441-9.

18.

Alternative splicing variant of kallikrein-related peptidase 8 as an independent predictor of unfavorable prognosis in lung cancer.

Planque C, Choi YH, Guyetant S, Heuzé-Vourc'h N, Briollais L, Courty Y.

Clin Chem. 2010 Jun;56(6):987-97. doi: 10.1373/clinchem.2009.138917. Epub 2010 Apr 1.

19.

Expression and function of the kallikrein-related peptidase 6 in the human melanoma microenvironment.

Krenzer S, Peterziel H, Mauch C, Blaber SI, Blaber M, Angel P, Hess J.

J Invest Dermatol. 2011 Nov;131(11):2281-8. doi: 10.1038/jid.2011.190. Epub 2011 Jul 14.

20.

Prognostic significance of multiple kallikreins in high-grade astrocytoma.

Drucker KL, Gianinni C, Decker PA, Diamandis EP, Scarisbrick IA.

BMC Cancer. 2015 Aug 1;15:565. doi: 10.1186/s12885-015-1566-5.

Supplemental Content

Support Center